| Peripheral nervous system in gyrate atrophy of the choroid and retina with hyperornithinemia. | |
| | |
MedLine Citation:
|
PMID: 12221166 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To evaluate peripheral nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinemia (GA). BACKGROUND: GA is an inborn error of amino acid metabolism caused by mutations in the enzyme ornithine aminotransferase. Patients with GA have hyperornithinemia, progressive centripetal loss of vision, minor CNS abnormalities, and type II muscle fiber atrophy with accumulation of tubular aggregates. The authors previously showed that muscle and brain creatine stores are depleted in the patients with GA. METHODS: The authors searched evidence of peripheral nervous involvement in 40 patients with GA (mean age 31.6 +/- 16.3 years; range 5 to 74 years) by using neurography, quantitative sensory threshold testing, and evoked potential testing. RESULTS: Neurography revealed abnormalities in 21 (53%) of the patients. The abnormalities associated with the severity of the ophthalmologic changes and the age of the patients. With quantitative sensory threshold testing, abnormal large-fiber function was found in seven (18%) and abnormal small-fiber function was found in four (10%) patients. Somatosensory evoked potential and brainstem auditory evoked potential responses were abolished in five patients. CONCLUSIONS: These findings of peripheral nervous system involvement in GA suggest that GA is a systemic disease affecting not only CNS but also the peripheral nervous system. |
| | |
Authors:
|
K E Peltola; S Jääskeläinen; O J Heinonen; B Falck; K Näntö-Salonen; K Heinänen; O Simell |
Related Documents
:
|
20066616 - Electrophysiological findings in patients with adult tethered cord syndrome. 6275306 - Absence of evoked potential abnormalities in acute transverse myelopathy. 8437696 - Magnetic resonance imaging in hereditary and idiopathic ataxia. 8595486 - Autosomal dominant cerebellar ataxia type i in martinique (french west indies). clinica... 12847366 - Characterization and clinical behavior of crohn's disease initially presenting predomin... 564176 - The management of vaginismus. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Neurology Volume: 59 ISSN: 0028-3878 ISO Abbreviation: Neurology Publication Date: 2002 Sep |
Date Detail:
|
Created Date: 2002-09-10 Completed Date: 2002-10-04 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0401060 Medline TA: Neurology Country: United States |
Other Details:
|
Languages: eng Pagination: 735-40 Citation Subset: AIM; IM |
Affiliation:
|
Department of Pediatrics, Turku University Central Hospital, Turku, Finland. katja.peltola@utu.fi |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Choroid Diseases / blood, genetics, physiopathology* Electromyography Evoked Potentials, Auditory, Brain Stem Evoked Potentials, Somatosensory Female Founder Effect Gyrate Atrophy / blood, genetics, physiopathology* Homozygote Humans Male Middle Aged Ornithine / blood* Peripheral Nervous System / physiopathology* Retinal Diseases / blood, genetics, physiopathology* Sensory Thresholds |
| Chemical | |
Reg. No./Substance:
|
7006-33-9/Ornithine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Survival in transgenic ALS mice does not vary with CNS glutathione peroxidase activity.
Next Document: Cognitive performance after coronary artery bypass grafting: a follow-up study.